News
- Author:
- Miriam E. Tucker
Publish date: December 1, 2022
The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost effectively identify those at risk who could potentiall...
News
- Author:
- Miriam E. Tucker
Publish date: November 18, 2022
Teplizumab delayed progression to clinical type 1 diabetes by about 2 years compared with placebo in individuals destined to develop the condition ...
News
- Author:
- Miriam E. Tucker
Publish date: November 14, 2022
The increasing popularity of continuous glucose monitoring devices in prediabetes and for ‘wellness’ prompts discussion about appropriate use and p...
News
- Author:
- Miriam E. Tucker
Publish date: November 2, 2022
“At this stage, I believe it is most important to be physically active in general. So ... if the morning is the only time of the day to go for a wa...
News
- Author:
- Miriam E. Tucker
Publish date: October 26, 2022
A genetic approach provides support for the effects of vitamin D on mortality. The benefits of vitamin D supplementation are largely found in those...
News
- Author:
- Miriam E. Tucker
Publish date: October 25, 2022
Confusion with the term ‘diabetes mellitus’ ... has spurred proposed name change by an international panel representing major endocrinology societi...
News
- Author:
- Miriam E. Tucker
Publish date: October 19, 2022
Long-term insulin independence and safety is seen with islet-cell transplant in patients with severe hypoglycemia at baseline.
News
- Author:
- Miriam E. Tucker
Publish date: October 19, 2022
Americans with private insurance are more likely to ration insulin than are those with public health insurance and the insulin-treated diabetes pop...
Article
- Author:
- Miriam E. Tucker
Publish date: October 12, 2022
“Double-blind and placebo-controlled clinical trials are needed to see whether the drug [TDZ] could help lower dementia risk in people with and wit...
News
- Author:
- Miriam E. Tucker
Publish date: October 12, 2022
A new consensus statement covers the benefits, limitations, and challenges of automated insulin delivery systems and provides recommendations for u...
News
- Author:
- Miriam E. Tucker
Publish date: October 4, 2022
Relationship is particularly high within 1 month of type 1 diabetes onset, suggesting potential preventive role for vaccination or antivirals.
News
- Author:
- Miriam E. Tucker
Publish date: September 30, 2022
Novo Nordisk’s insulin icodec was superior in lowering A1c compared with daily degludec without increasing the risk for moderate or severe hypoglyc...
News
- Author:
- Miriam E. Tucker
Publish date: September 27, 2022
Most people with existing and new-onset type 1 diabetes are adults, and much of the increase is expected in low- and middle-income countries.
News
- Author:
- Miriam E. Tucker
Publish date: September 27, 2022
No major changes but several shifts in emphasis since the last update in 2019, including weight loss as a co–primary goal of management.
News
- Author:
- Miriam E. Tucker
Publish date: September 22, 2022
Study following people for over 30 years from the time of type 1 diabetes diagnosis finds increasing risk of complications with A1c levels above a ...
